THE APEX TIMES
In its third-quarter 2026 investor letter, Bireme Capital said it sold its Moderna position (MRNA) following a major rally, while reporting strong portfolio performance for its “Fundamental Value” strategy.
Bireme Capital said it sold its Moderna investment after the drugmaker’s shares ran sharply higher, according to the manager’s third-quarter 2026 investor letter published alongside a news report by Yahoo Finance.
The report ties the decision to Moderna’s stock “record rally,” but it does not provide the specific timing of the trades, the size of the position before sale, or whether the exit was partial or complete. It also does not lay out a detailed valuation framework for why the company’s fundamentals had stopped justifying ownership, beyond referencing the rally context.
Bireme’s letter highlighted performance for its “Fundamental Value” approach, which it said returned 9.7% net of fees in the third quarter, compared with 2.4% in the prior period referenced in the report. The disclosure is framed at the strategy level rather than as a performance attribution tied specifically to Moderna.
The investor letter, as described in the report, indicates that the Moderna decision was part of a broader portfolio review process rather than a single-company event. Still, the article does not specify what other holdings changed in the quarter, nor does it describe any particular catalyst, regulatory step, or commercial update that drove the sale.
Moderna, a biotechnology company focused on messenger RNA (mRNA) therapeutics and vaccines, has repeatedly been judged by investors on how quickly its pipeline can convert into durable revenue streams. For managers using fundamental-value style investing, that usually means weighing near-term commercialization against longer-cycle development timelines.
Even without additional detail in the Yahoo Finance report, the action reflects a common pattern in high-volatility biotech stocks: when shares re-rate rapidly, valuation becomes harder to underwrite, and some investors reduce exposure even if they remain constructive on the technology.
The most important limitation is that the report’s description does not include the full letter text, nor does it quote Bireme Capital’s reasoning in detail. As a result, readers do not yet have information on Bireme’s updated view of Moderna’s prospects, its estimate of intrinsic value, or whether it plans to re-enter the position if the stock’s valuation changes.
Looking ahead, the key item to watch is whether Bireme Capital’s later investor letters clarify its framework for selling winners in biotech, and whether Moderna investors see follow-through on the factors that likely supported the stock’s “record rally.”
In an interview segment carried by Yahoo Finance, Tesla CEO Elon Musk addressed political spending he said he made during the midterms, adding that the outcome left him questioning the scale.
A market note points to high-teens advertising growth in Q4 2026, with Amazon betting that newer AI ad tools and premium video inventory can keep expanding even as infrastructure expenses rise.
A new C-5 Galaxy support arrangement totaling $316.6 million underscores how Lockheed Martin is leaning on aircraft sustainment and services to support long-term growth.
A new market note weighs Mastercard’s established payments franchise against Nu’s faster-growing Latin America digital banking push, framing the debate around valuation and uncertainty rather than short-term business traction.
Shares of Netflix declined about 15% over a month as investors digested a cautious view of near-term performance and a reduction in the company’s 2026 advertising revenue outlook.
The company said proposed labor protections under consideration by the New York City Council could increase fulfillment costs, drawing a public response from the retail and logistics giant.
A new market outlook projects the software-as-a-service industry will expand sharply by 2035, highlighting a move away from seat-based licensing toward AI-driven “agents.” Adobe is named among the major vendors expected to benefit as enterprise software adds agent-like capabilities.
In its latest quarter update, Walmart pointed to fulfillment speed as a key reason its U.S. e-commerce business expanded 23% in Q3.
The retailer is building out last-mile capabilities for contractor customers, using new flatbed distribution centers alongside acquisitions and technology improvements, according to reporting.
A third-quarter 2026 investor letter from Carillon Tower Advisers discussed AT&T as part of the Carillon Eagle Growth & Income Fund’s performance review, framing the period around execution and results rather than headline macro narratives.
Comments
Community guidelines. Comments may be removed for violations.
Loading comments...